Connection
Jennifer Trujillo to Venoms
This is a "connection" page, showing publications Jennifer Trujillo has written about Venoms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.202 |
|
|
|
-
Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9.
Score: 0.110
-
Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
Score: 0.092